Evaluation of Discrepancies in Valganciclovir Dosing Based on Creatinine Clearance and Estimated Glomerular Filtration Rate for Cytomegalovirus Prevention in Kidney Transplant Patients (ATC 2026) - Jun 17, 2026 - Abstract #Abstract A291; Pres time: Jun 20, 2026; 05:45 PM - 06:45 PM; Location: Exhibit Hall; "A total of 86 patients were included in the initial data pull and 9 were excluded due to receiving acyclovir prophylaxis.* Of the 77 patients receiving VGC, 44 (57.1%) demonstrated discrepancies in recommended doses between the C-G and eGFR equation estimates...About 17% of all patients switched to letermovir to complete therapy with similar rates between the dosing groups... Using the eGFR equation to assess kidney function and provide VGC dosing recommendations allows providers to approach target doses with no observed increase in adverse effects or treatment failure."
Clinical • Cytomegalovirus Infection • Hematological Disorders • Leukopenia • Transplantation
|
|
K. Diehl; T. Anderson-Haag; A. Spenningsby
|